Why is Himadri Special falling/rising?

Nov 22 2025 12:21 AM IST
share
Share Via
On 21-Nov, Himadri Speciality Chemical Ltd’s stock price fell by 1.47% to ₹440.00, continuing a recent downward trend amid a combination of disappointing quarterly results and valuation concerns despite strong long-term growth metrics.




Recent Price Performance and Market Comparison


Himadri Speciality Chemical’s stock has been on a downward trajectory over the past week and month, falling by 3.19% and 5.88% respectively, while the Sensex gained 0.79% and 0.95% over the same periods. Year-to-date, the stock has declined sharply by 24.78%, contrasting starkly with the Sensex’s 9.08% rise. Over the last year, the stock’s return was negative 8.90%, whereas the Sensex appreciated by 10.47%. Despite this recent weakness, the company’s longer-term performance remains impressive, with a three-year gain of 348.29% and a five-year surge exceeding 1,000%, significantly outperforming the Sensex’s respective 39.39% and 94.23% returns.


Technical Indicators and Trading Activity


On the technical front, Himadri Speciality Chemical is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend. The stock has also recorded losses for two consecutive days, with a cumulative decline of 2.74% during this period. However, investor participation appears to be rising, as delivery volumes on 20 Nov surged by 51.07% to 2.71 lakh shares compared to the five-day average, indicating increased trading interest despite the price fall. Liquidity remains adequate, supporting trade sizes up to ₹0.35 crore without significant market impact.



Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.



  • - Investment Committee approved

  • - 50+ candidates screened

  • - Strong post-announcement performance



See Why It Was Chosen →



Fundamental Strengths and Concerns


Himadri Speciality Chemical boasts a relatively low average debt-to-equity ratio of 0.20 times, which is favourable for financial stability. The company has demonstrated robust long-term growth, with net sales increasing at an annual rate of 25.37% and operating profit expanding by 65.69%. These figures underscore the firm’s operational efficiency and growth potential over the medium to long term.


However, recent quarterly results have been less encouraging. The company reported flat performance in September 2025, with net sales for the quarter falling by 5.4% compared to the previous four-quarter average, signalling a slowdown in revenue generation. Additionally, interest expenses have surged by 49.17% over the latest six months, reaching ₹30.61 crore, which may pressure profitability. The half-year debt-to-equity ratio has also risen sharply to 1.99 times, indicating increased leverage that could raise financial risk.


Valuation and Market Sentiment


Despite a return on equity (ROE) of 16.1%, the stock is considered expensive, trading at a price-to-book value of 5.5 times. This premium valuation places it above its peers’ historical averages, which may deter value-conscious investors. Moreover, the stock’s price-to-earnings-to-growth (PEG) ratio stands at 1, reflecting a balance between earnings growth and valuation but not offering a compelling discount. The disconnect between rising profits—up 36.1% over the past year—and negative stock returns suggests that market participants remain cautious, possibly due to the recent operational and financial headwinds.



Why settle for Himadri Special? SwitchER evaluates this Specialty Chemicals Smallcap against peers, other sectors, and market caps to find you superior investment opportunities!



  • - Comprehensive evaluation done

  • - Superior opportunities identified

  • - Smart switching enabled



Discover Superior Stocks →



Conclusion: Why the Stock is Falling


The decline in Himadri Speciality Chemical’s share price on 21-Nov and in recent weeks can be attributed to a combination of factors. The company’s recent quarterly sales contraction and rising interest costs have raised concerns about near-term earnings momentum and financial leverage. These issues, coupled with the stock’s elevated valuation metrics, have likely contributed to investor caution and selling pressure. Furthermore, the stock’s underperformance relative to the broader market and sector indices over multiple time frames reinforces a negative sentiment among market participants. While the company’s long-term growth story remains intact, the current financial and valuation challenges are weighing on the share price, resulting in the observed decline.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News